Table 3.
Total Joint Arthroplasty Complications and Readmission Rates.
| Variable | No Statins (n = 966) | Prior Statins (n = 572) | Perioperative Statin (n = 231) | Perioperative Statin vs No Statin P-Value | No Statin vs Perioperative + Prior Statin P-Value | Perioperative Statin vs Prior Statin P-Value |
|---|---|---|---|---|---|---|
| 90-d readmission (%) | 38 (3.9%) | 31 (5.4%) | 15 (6.5%) | .107 | .092 | .615 |
| MUA (%) | 7 (0.7%) | 2 (0.3%) | 3 (1.3%) | .417 | 1.00 | .498 |
| VTE (%) | 15 (1.6%) | 10 (1.7%) | 3 (1.3%) | 1.00 | 1.00 | 1.00 |
| Infection (%)a | 26 (2.7%) | 19 (3.3%) | 5 (2.2%) | .819 | .774 | .798 |
| Dislocation (%)b | 5 (0.5%) | 1 (0.6%) | 2 (1.9%) | .322 | 1.00 | .483 |
MUA, manipulation under anesthesia; VTE, venousthromoembolic event.
a
Infections included both superficial and deep wound infections, urinary tract infections, respiratory and gastrointestinal infections.
b
Total hip arthroplasty patients only.